HERON THERAPEUTICS, INC. /DE/ (HRTX) Share-based Payment Arrangement, Expense USD 2012 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Heron Therapeutics, Inc. /De/ quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2012 to 2024.
  • Heron Therapeutics, Inc. /De/ Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $3.38 M, a 57.5% decline year-over-year.
  • Heron Therapeutics, Inc. /De/ Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2024 was $28.3 M, a 29.3% decline year-over-year.
  • Heron Therapeutics, Inc. /De/ annual Share-based Payment Arrangement, Expense for 2023 was $32.9 M, a 23.6% decline from 2022.
  • Heron Therapeutics, Inc. /De/ annual Share-based Payment Arrangement, Expense for 2022 was $43 M, a 8.26% decline from 2021.
  • Heron Therapeutics, Inc. /De/ annual Share-based Payment Arrangement, Expense for 2021 was $46.9 M, a 6.71% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $28.3 M $3.38 M -$4.57 M -57.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $32.9 M $4.32 M -$6.19 M -58.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-12
Q3 2023 $39 M $6.68 M -$4.52 M -40.3% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $43.6 M $13.9 M +$3.55 M +34.3% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $40 M $7.95 M -$2.97 M -27.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $43 M $10.5 M -$2.37 M -18.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-12
Q3 2022 $45.4 M $11.2 M -$38 K -0.34% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $45.4 M $10.4 M -$888 K -7.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $46.3 M $10.9 M -$571 K -4.97% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $46.9 M $12.9 M -$3.15 M -19.6% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-29
Q3 2021 $50 M $11.2 M +$141 K +1.27% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $49.9 M $11.2 M +$127 K +1.14% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $49.7 M $11.5 M -$488 K -4.08% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $50.2 M $16 M +$4.94 M +44.5% Oct 1, 2020 Dec 31, 2020 10-K 2022-02-28
Q3 2020 $45.3 M $11.1 M +$1.39 M +14.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $43.9 M $11.1 M -$1.59 M -12.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $45.5 M $12 M -$5.93 M -33.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 $51.4 M $11.1 M +$1.3 M +13.3% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-28
Q3 2019 $50.1 M $9.7 M +$1.65 M +20.5% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $48.5 M $12.7 M +$4.89 M +62.5% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 $43.6 M $17.9 M +$10.2 M +132% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 $33.4 M $9.8 M +$2.9 M +42.1% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-24
Q3 2018 $30.5 M $8.05 M +$574 K +7.68% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $29.9 M $7.82 M -$329 K -4.04% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-05
Q1 2018 $30.2 M $7.7 M -$320 K -3.99% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $30.5 M $6.89 M -$368 K -5.07% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-02
Q3 2017 $30.9 M $7.48 M -$35 K -0.47% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 $30.9 M $8.15 M +$2.32 M +39.8% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 $28.6 M $8.02 M +$2.67 M +49.8% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $26 M $7.26 M +$1.41 M +24.1% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-22
Q3 2016 $24.5 M $7.51 M +$4.69 M +166% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-06
Q2 2016 $19.9 M $5.83 M +$2.69 M +85.6% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 $17.2 M $5.36 M +$2.8 M +110% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 $14.4 M $5.85 M +$3.59 M +159% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-27
Q3 2015 $10.8 M $2.82 M +$1.06 M +60.3% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-08
Q2 2015 $9.71 M $3.14 M +$2.06 M +191% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 $7.65 M $2.55 M -$418 K -14.1% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-05
Q4 2014 $8.07 M $2.26 M -$299 K -11.7% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-23
Q3 2014 $8.37 M $1.76 M -$2.34 M -57% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 $10.7 M $1.08 M -$1.32 M -55.1% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 $12 M $2.97 M +$1.13 M +61.8% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-08
Q4 2013 $10.9 M $2.56 M +$598 K +30.5% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-19
Q3 2013 $10.3 M $4.1 M +$2.12 M +107% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-06
Q2 2013 $8.18 M $2.4 M +$1.39 M +137% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-04
Q1 2013 $6.79 M $1.84 M +$1.06 M +136% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q4 2012 $5.73 M $1.96 M Oct 1, 2012 Dec 31, 2012 10-K 2015-03-13
Q3 2012 $1.98 M Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 $1.02 M Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-08
Q1 2012 $778 K Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.